In this month’s Bulletin
Bulletin of the World Health Organization 2012;90:793-793. doi: 10.2471/BLT.12.001112
In this issue, Steven J Hoffman & John-Arne Røttingen (854–864) assess options for a global research and development agreement. In related editorials, Benn McGrady (794) weighs the legal implications of choices made by Member States, Carlos M Correa (795) details the potential features of a new model for pharmaceutical research and James Love (796) discusses different possibilities for its scope.
In another editorial, Abdul Ghaffar et al. (797) announce a new strategy on health policy and systems research.
In an interview, Haibo Wang (802–803) talks to Fiona Fleck about China’s new system for organ donation. Michael Dumiak (800–802) reports on efforts to revise influenza pandemic plans.
Siddhivinayak Hirve et al. (804–812) compare case definitions of influenza.
Using primary health care
Christine Buttorff et al. (813–821) count the costs of managing common mental disorders.
Asif Raza Khowaja et al. (822–830) survey parents on their reasons for declining polio vaccination.
Sara V Flanagan et al. (839–846) uncover the impact of arsenic exposure.
Syrian Arab Republic, Tunisia, Turkey, West Bank & Gaza Strip
Evidence into policy
Sarah Bowman et al. (847–853) describe how evidence on diabetes and coronary heart disease can inform public policies.
A user’s guide
Kelsey K Case et al. (831–838) clarify how a transmission model is used for planning HIV prevention strategies.
Making the most of new technology
Vasee S Moorthy et al. (864–866) discuss the research needed to guide decisions on future vaccines for malaria.
Joseph Kutzin (867–868) cautions readers on detours in the path to universal health coverage.